British Journal of Pharmacology · 1983 · 11 citations · 16 references
Prostaglandin Synthesis InhibitorsPharmacotherapyExperimental PharmacologyOxidative StressMolecular PharmacologyContractile ResponseMyometrial ContractilityAnesthetic PharmacologyAngiotensin Ii‐Molecular PhysiologyEndocrine MechanismArachidonic AcidVascular PharmacologyVascular BiologyRat UterusEndocrinologyPharmacologyPhysiologyUterine ReceptivityMedicine
1 Eicosatetraynoic acid, the acetylene analogue of arachidonic acid, which inhibits both the cyclo-oxygenase and lipoxygenase pathways, reduced the contractile response of rat uterine smooth muscle to either angiotensin II or oxytocin. 2 Indomethacin, an inhibitor of cyclo-oxygenase, did not reduce the response to angiotensin II but did abolish the contractile response to low doses of oxytocin. 3 Nordihydroguaiaretic acid, a lipoxygenase inhibitor, totally abolished the uterine response to either oxytocin or angiotensin II. 4 The contractile response to carbachol, a cholinoceptor agonist, was unaffected by pretreatment with any of the cyclo-oxygenase or lipoxygenase inhibitors. 5 From these findings, it can be implied that some product of the arachidonate lipoxygenase pathway augments peptide-induced contractions of the rat uterus.
16